Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Baxter
Deloitte
Daiichi Sankyo
Merck
AstraZeneca
Harvard Business School
Accenture
Healthtrust

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020750

« Back to Dashboard

NDA 020750 describes TILADE, which is a drug marketed by King Pharms Llc and Sanofi Aventis Us and is included in two NDAs. Additional details are available on the TILADE profile page.

The generic ingredient in TILADE is nedocromil sodium. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the nedocromil sodium profile page.
Summary for 020750
Tradename:TILADE
Applicant:Sanofi Aventis Us
Ingredient:nedocromil sodium
Patents:0
Therapeutic Class:Ophthalmic Agents
Respiratory Tract Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 020750

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;INHALATIONStrength0.5%
Approval Date:Oct 1, 1997TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Daiichi Sankyo
Express Scripts
Merck
Farmers Insurance
AstraZeneca
Baxter
Chubb
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.